BMRN News Today: Stay Updated with the Latest BioMarin Pharmaceutical Inc. News in Real Time
Find BMRN news now at Meyka AI. Stay informed with the latest BioMarin Pharmaceutical Inc. stocks updates, including price news, market analysis, and expert insights.
NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline
NVIDIA shares fell 1.78% in pre-market trading on June 10, 2026, leading a broader decline across AI chip stocks. AMD dropped 3.02%, while Intel and Micron also traded lower as investors reacted to renewed concerns over inflation, interest rates, and technology valuations. The selloff comes after a powerful AI-driven rally that pushed semiconductor stocks to…
SK Hynix Eyes U.S. Listing as Early as August Amid Strong AI Stock Demand
SK Hynix is moving closer to a major milestone in its global growth strategy. Reports on June 10, 2026, revealed that the South Korean memory-chip giant is considering a U.S. stock market listing as early as August. The timing comes as artificial intelligence continues to fuel strong demand for advanced semiconductor companies. With investors pouring…
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….
Top Indian Stocks: Ajanta Pharma, Bharti Airtel, IndiGo Lead Watchlist Amid Global Market Weakness
Indian equities entered the June 10 session with caution as global markets remained under pressure from rising crude oil prices and geopolitical concerns. Despite the weak backdrop, a few key stocks stood out due to major corporate developments, regulatory relief, and ownership changes. Market participants are closely tracking Ajanta Pharma, Bharti Airtel, and IndiGo as…
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…
United Natural Foods Stock Plunges 11% After $7.72B Revenue Miss and Weak FY2026 Outlook
Revenue came in. The stock came down. United Natural Foods (NYSE: UNFI) reported fiscal Q3 2026 results before the market open on June 9, 2026, covering the 13 weeks ended May 2, 2026. Wall Street had set the bar at $7.80 billion in revenue and $0.77 EPS, based on consensus estimates from 10 analysts. The…
CoreWeave Inc Stock Gains 2.74% in Pre-Market as Founders Sell $2.3B Shares Post-IPO
CoreWeave Inc stock is in focus after a sharp pre-market move. The shares climbed about 2.74% even as news emerged that company founders sold nearly $2.3 billion worth of shares after the IPO. This kind of movement often creates confusion in the market. Normally, large insider selling can pressure a stock. But here, the price…
GSK to Buy Nuvalent for $10.6 Billion, Paying $124 Per Share in All-Cash Deal
GSK has made a major move in the global pharmaceutical industry. The company has agreed to acquire Nuvalent for $10.6 billion in an all-cash deal. The offer price is $124 per share, which is about a 40% premium compared to the last closing price of Nuvalent. This is not a small deal. It is one…
Panacea Biotec Soars 15% to 52-Week High After Launch of EU-Funded DENSTAR Project
Panacea Biotec became one of the biggest gainers in the healthcare sector after its shares surged nearly 15 percent and touched a fresh 52-week high. The rally came after the company announced the launch of the DENSTAR Project, a major international initiative aimed at accelerating the regulatory approval and deployment of its dengue vaccine in…